Browsing by Author Baran, Yusuf

Showing results 64 to 83 of 174 < previous   next >
Issue DateTitleAuthor(s)
2014Expression levels of ceramide-metabolising genes in newly diagnosed and tyrosine kinase inhibitor-resistant chronic myeloid leukemia (CML) patients: The discovery of novel targets in CMLYandım, Melis Kartal; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, O.; Özcan, Mehmet Ali; Saydam, Göksel; Baran, Yusuf 
2015Expression levels of JAK/STAT signaling genes in newly diagnosed, drug sensitive and resistant chronic myeloid leukemia patientsKiraz, Yağmur ; Saydam, Güray; Şahin, Fahri; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Baran, Yusuf 
2014Expression levels of JAK/STAT signaling genes in newly diagnosed, drug sensitive and resistant chronic myeloid leukemia patientsKiraz, Yağmur 
Feb-2017Flow cytometry: basic principles and applicationsAdan, Aysun ; Alizada, Günel; Kiraz, Yağmur ; Baran, Yusuf ; Nalbant, Ayten 
Mar-2014Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphomaÖmür, Özgür; Baran, Yusuf ; Oral, Aylin; Ceylan, Yeşim
2013Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Extranodal Staging of Non-Hodgkin Lymphoma and Hodgkin DiseaseÖmür, Özgür; Baran, Yusuf ; Oral, Aylin; Ceylan, Yeşim
2023ForewordBaran, Y. 
2010Gene expression profiles in resveratrol applied acute promyelocytic leukemia cellsBaran, Yusuf ; Çakır, Zeynep; Can, Geylani; Saydam, Güray; Şahin, Fahri
2010Gene expression profiles in resveratrol-induced cell death in acute promyelocytic leukemia cellsÇakır, Zeynep; Can, Geylani; Saydam, Güray; Şahin, Fahri; Baran, Yusuf 
2015A genome-wide analyses of differentially expressed genes and related networks affected by fisetin and hesperetin in chronic myeloid leukemia cellsAdan Gökbulut, Aysun ; Baran, Yusuf 
2013Gossypol interferes with both type I and Type II topoisomerase activities without generating strand breaksŞenarısoy, Müge; Cantürk, Pakize; Zencir, Sevil; Baran, Yusuf ; Topçu, Zeki
2013Granulocytic sarcoma: a systematic reviewYılmaz, Asu Fergün; Saydam, Güray; Şahin, Fahri; Baran, Yusuf 
2023HER2-specific peptide (LTVSPWY) and antibody (herceptin) targeted core cross-linked micelles for breast cancer: A Comparative studyBayram, N.N.; Ulu, G.T.; Abdulhadi, N.A.; Gürdap, S.; İşoğlu, İ.A.; Baran, Yusuf ; İşoğlu, S.D.
2022HER2-Targeted, Degradable Core Cross-Linked Micelles for Specific and Dual pH-Sensitive DOX ReleaseBayram, N.N.; Ulu, G.T.; Topuzoğulları, M.; Baran, Y. ; Dinçer, İşoğlu, S.
28-Oct-2021HER2-targeted, degradable core cross-linked micelles for specific and dual pH-sensitive DOX releaseBayram, Nazende Nur; Ulu, Gizem Tuğçe ; Topuzoğulları, Murat; Baran, Yusuf ; Dinçer İşoğlu, Sevil
2018Hesperidin promotes programmed cell death by downregulation of nongenomic estrogen receptor signalling pathway in endometrial cancer cellsCincin, Zeynep Birsu; Kıran, Bayram; Baran, Yusuf ; Çakmakoğlu, Bedia
2011Hormona dirençli prostat kanseri hücrelerinde dosetaksel ve seramidin induklediği apoptozisde seramid genlerinin ve ürünlerinin eksprersyon düzeylerinin araştırılmasıBaran, Yusuf 
Mar-2011Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cellsCan, Geylani; Ekiz, Hüseyin Atakan ; Baran, Yusuf 
2009Imatinib induces autophagy through increasing the expression levels of Beclin-1 and ATG-5 genes in both parental sensitive and imatinib-resistant K562 cellsBaran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan ; Genç, S. G.
6-Dec-2011Imatinib-induced apoptosis: A possible link to topoisomerase enzyme inhibitionBaran, Yusuf ; Zencir, Sevil; Çakır, Zeynep; Öztürk, Esra; Topçu, Zeki